Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2020-04-17 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
公司章程（2020年4月）
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Zhejiang Huatong Pharmaceutical Co., Ltd. It contains detailed company governance rules, shareholder rights, board structure, share issuance and transfer rules, meeting procedures, and other corporate governance matters. It references compliance with Chinese Company Law and Securities Law, and includes detailed provisions on shareholder meetings, board of directors, management, and financial meeting systems. The document is lengthy (15,000 characters) and is a foundational governance document rather than a report of financial results or an announcement. It is not an Annual Report, Interim Report, Earnings Release, or any financial statement. It is not a proxy statement or voting results announcement. It is not a regulatory filing or legal proceeding update. It is a governance document detailing the company's internal rules and structure. Therefore, the appropriate classification is Governance Information (CGR).
2020-04-17 Chinese
华金证券股份有限公司关于公司2019年度内部控制自我评价报告的核查意见
Regulatory Filings Classification · 95% confidence The document is titled as an internal control self-evaluation report verification opinion for the year 2019 by Huajin Securities Co., Ltd. regarding Zhejiang Huatong Pharmaceutical Co., Ltd. It references regulatory guidelines related to securities issuance and listing, and details the scope, standards, and findings of the internal control evaluation. The document is a verification opinion by the sponsor institution on the company's internal control self-evaluation report, not the report itself. The length is 3488 characters, which is relatively short and consistent with an opinion or verification letter rather than a full report. It does not contain full financial statements or substantive financial data but rather an assessment and opinion on the internal control report. Therefore, it is best classified as a Regulatory Filing (RNS), which covers compliance documents and attestations that do not fit other categories.
2020-04-17 Chinese
华金证券股份有限公司关于公司2019年度保荐工作报告
Audit Report / Information Classification · 90% confidence The document is titled as a '2019年度保荐工作报告' which translates to '2019 Annual Sponsorship Work Report' by 华金证券股份有限公司 regarding 浙江华通医药股份有限公司. It details the sponsorship work overview, supervision of fundraising, governance, internal controls, and compliance with regulatory requirements. The document includes tables summarizing work content, issues found, and measures taken, as well as company and shareholder commitments. It is a detailed report on the sponsor's activities and oversight related to the company for the year 2019. The document length is 2088 characters, which is relatively short but contains substantive content about the sponsor's work rather than just an announcement or certification. This type of report is specific to the sponsor's regulatory and compliance duties rather than a general annual report or financial statement. It does not fit into categories like Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is not a regulatory filing or announcement but a detailed work report by the sponsor. Given the nature of the document, it aligns best with Audit Report / Information (AR) as it relates to oversight, review, and compliance activities by the sponsor, which is akin to audit or supervisory reporting. Therefore, the most appropriate classification is AR with high confidence. FY 2019
2020-04-17 Chinese
独立董事关于公司续聘审计机构事前认可意见
Board/Management Information Classification · 90% confidence The document is a statement from independent directors regarding the pre-approval of the company's reappointment of an audit firm. It references regulatory guidelines and confirms the suitability and independence of the audit firm for the upcoming board meeting. The content is focused on governance and audit firm appointment rather than presenting audit results or financial data. It is not a full audit report or annual report but a governance-related announcement about audit firm reappointment. Therefore, it fits best under Board/Management Information (MANG) as it relates to board-level decisions and approvals.
2020-04-17 Chinese
2019年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2019 by Zhejiang Huatong Pharmaceutical Co., Ltd. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2019, including financial and non-financial internal control defect assessments, standards used, and conclusions. The content is detailed and specific to internal control evaluation rather than a full annual report or audit report. It is not a brief announcement or a certification letter but a substantive report on internal control. This type of document aligns best with an Audit Report / Information (AR) category, which includes standalone audit reports and internal control evaluations, excluding full annual reports. The document length (3531 characters) is relatively short but contains detailed internal control evaluation content, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2019
2020-04-17 Chinese
独立董事2019年度述职报告（章勇坚）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2019 Annual Work Report" for Zhejiang Huatong Pharmaceutical Co., Ltd. It details the independent director's activities, attendance at board and shareholder meetings, opinions on various company matters, and supervision of company governance during the 2019 fiscal year. The content is a narrative report of the independent director's duties and opinions rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it an announcement of voting results or a proxy statement. It is a management-related report focusing on governance and oversight by an independent director. Therefore, the document fits best under the category of Board/Management Information (MANG), which covers announcements related to board members and their activities.
2020-04-17 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.